Patents by Inventor Elizabeth Stanton

Elizabeth Stanton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazine substituted pyrrolopyridines as inhibitors of JAK and PDK1
    Patent number: 8183245
    Abstract: The present invention relates to pyrazine substituted pyrrolopyridines having formula (I) useful as inhibitors of JAK kinases (JAK1, JAK2, JAK3 and/or TYK2) and/or PDK1 and for the treatment of myeloproliferative disorders or other cancers.
    Type: Grant
    Filed: October 21, 2008
    Date of Patent: May 22, 2012
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: David J. Guerin, Joos Jung, Elizabeth Stanton
  • THERAPEUTIC COMPOUNDS
    Publication number: 20100210623
    Abstract: The present invention relates to pyrazine substituted pyrrolopyridines which are inhibitors of JAK kinases (JAK1, JAK2, JAK3 and/or TYK2) and/or PDK1 and are thus useful for the treatment of myeloproliferative disorders or cancer.
    Type: Application
    Filed: October 21, 2008
    Publication date: August 19, 2010
    Inventors: David J. Guerin, Joon Jung, Elizabeth Stanton